• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Piperacillin and Tazobactam (Zosyn) Injection

 Status: Currently in Shortage

 » Date first posted: 04/02/2014
 » Therapeutic Categories: Anti-Infective; Pediatric

Apotex Corp. (Reverified 01/27/2016)

Company Contact Information:
800-706-5575

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.25 gm/vial (10 Vials) (NDC 60505-0686-4) On backorder Temporary Discontinuation of the manufacture of the drug due to API issues. Production to resume in Dec 2015 Demand increase in the drug
3.75 gm/vial (10 Vials) (NDC 60505-0687-4) On backorder Temporary Discontinuation of the manufacture of the drug due to API issues. Production to resume in Dec 2015 Demand increase in the drug
4.5 gm/vial (10 Vials) (NDC 60505-0688-4) On backorder Temporary Discontinuation of the manufacture of the drug due to API issues. Production to resume in Dec 2015 Demand increase in the drug
40.5 gm/vial (NDC 60505-0773-0) On backorder Temporary Discontinuation of the manufacture of the drug due to API issues. Production to resume in Dec 2015 Demand increase in the drug

Aurobindo Pharma (Revised 01/20/2015)

Company Contact Information:
732-839-9400

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.25 g SDV Cartons of 10 (NDC 55150-119-30) On intermittent back order; the company is releasing product as it becomes available. Check whole-salers for inventory. Other
3.375 g SDV Cartons of 10 (NDC 55150-120-30) On intermittent back order; the company is releasing product as it becomes available. Check whole-salers for inventory. Other
4.5 g SDV Cartons of 10 (NDC 55150-121-50) On intermittent back order; the company is releasing product as it becomes available. Check whole-salers for inventory. Other

Fresenius Kabi USA, LLC (Reverified 02/10/2016)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.25 g, single-dose vial (NDC 63323-309-20) Backordered. Increasing manufacturing and shipping upon release. Demand increase for the drug
3.375 g, single-dose vial (NDC 63323-300-30) Backordered. Increasing manufacturing and shipping upon release. Check wholesalers for inventory Demand increase for the drug
4.5 g, single-dose vial (NDC 63323-320-50) Backordered. Increasing manufacturing and shipping upon release. Demand increase for the drug
40.5 g, PBP (NDC 63323-304-74) Backordered. Increasing manufacturing and shipping upon release. Demand increase for the drug

Hospira, Inc. (Revised 02/05/2016)

Company Contact Information:
877-946-7747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.25 g Add-Vantage Vial (NDC 0409-3374-02) Available, releasing product consistently Demand increase for the drug
3.375 g; Add-Vantage Vial (NDC 0409-3378-13) Available, releasing product consistently Please check with your wholesaler for available inventory. Demand increase for the drug
4.5 g; Add-Vantage Vial (NDC 0409-3379-04) Available, releasing product consistently Demand increase for the drug
2.25 g; Vial (NDC 0409-3383-02) Available, releasing product consistently Please check with your wholesaler for available inventory. Demand increase for the drug
3.375 g; Vial (NDC 0409-3385-13) Next delivery: Early February 2016 and Estimated recovery Late 2Q 2016 Please check with your wholesaler for available inventory. Demand increase for the drug
4.5 g; Vial (NDC 0409-3390-04) Next delivery: Early February 2016 and Estimated recovery Late 2Q 2016 Demand increase for the drug

Mylan Institutional (Reverified 02/03/2016)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
3.375 g Pkg of 10 (NDC 67457-522-37) Available Demand increase for the drug

Pfizer Pharmaceuticals (Reverified 02/05/2016)

Company Contact Information:
800-533-4535

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Zosyn 2.25/50mL Frozen Bag 24's (NDC 0206-8860-02) Available Supporting all existing customers, but limited opportunities to support new frozen customers. Hospitals should contact their Pfizer Injectables sales rep to determine availability Increased market demand and capacity constraint
Zosyn 3.375/50mL Frozen Bags 24's (NDC 0206-8861-02) Available Supporting all existing customers, but limited opportunities to support new frozen customers. Hospitals should contact their Pfizer Injectables sales rep to determine availability Increased market demand and capacity constraint
Zosyn 4.5/100mL Frozen Bags 12's (NDC 0206-8862-02) Available Supporting all existing customers, but limited opportunities to support new frozen customers. Hospitals should contact their Pfizer Injectables sales rep to determine availability Increased market demand and capacity constraint
Zosyn 2.25g 10's (NDC 0206-8852-16) Unavailable Expected to resume shipments to customers in July 2016 Manufacturing Delays
Zosyn 3.375g 10's (NDC 0206-8854-16) Unavailable Expected to resume shipments to customers in July 2016 Manufacturing Delays
Zosyn 4.5g 10's (NDC 0206-8855-16) Unavailable Expected to resume shipments to customers in July 2016 Manufacturing Delays
Zosyn 40.5g Pharm Bulk 1's (NDC 0206-8859-10) Unavailable Estimated recovery Q2-2017 Sourcing Change

Sagent Pharmaceuticals (Reverified 02/10/2016)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.25mg 30mL vial, (NDC 25021-164-30) On allocation Demand increase for the drug
3.375g 30mL vial, (NDC 25021-165-30) On allocation Demand increase for the drug
4.5g 48mL vial, (NDC 25021-166-48) On allocation Demand increase for the drug

Sandoz (Reverified 02/01/2016)

Company Contact Information:
800-525-8747

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
4.5g (NDC 00781-3114-95) No more supply from this vendor Other
3.75g (NDC 00781-3113-95) No more supply from this vendor Other
2025g (NDC 00781-3110-95) Stock sold out. No more supply from this vendor. Other
3.75g (NDC 00781-3350-95) Supply in house. API availability Other

WG Critical Care (Revised 01/28/2016)

Company Contact Information:
888-493-0861

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
2.25g (NDC 44567-0801-10) Product on backorder Product continues to be manufactured, please check wholesalers for inventory. Increased demand for the product.
3.375g (NDC 44567-0802-10) Product on backorder Product continues to be manufactured, please check wholesalers for inventory. Increased demand for the product.
4.5g (NDC 44567-0803-10) Product on backorder Product continues to be manufactured, please check wholesalers for inventory. Increased demand for the product.
40.5g (NDC 44567-0804-01) Product on backorder Product continues to be manufactured, please check wholesalers for inventory. Increased demand for the product.
-
-